NCT06819228 2025-10-03
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
Vanderbilt-Ingram Cancer Center
Washington University School of Medicine